Ocean Biomedical Inc.

NASDAQ: OCEA · Real-Time Price · USD
0.01
0.00 (26.58%)
At close: Jun 09, 2025, 3:19 PM

Ocean Biomedical Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-9.48M -114.47M -958.43K -62.34M
Depreciation & Amortization
n/a n/a n/a n/a
Stock-Based Compensation
745K 1.21M n/a 56.55M
Other Working Capital
174K -52K 1.44M 4.74M
Other Non-Cash Items
3.51M 102.65M -1.52M -2.45K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
1.04M 1.18M 1.74M 4.74M
Operating Cash Flow
-4.18M -9.43M -747.3K -1.05M
Capital Expenditures
n/a n/a -3 n/a
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a -107.1M
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a -2.1M n/a
Investing Cash Flow
n/a n/a -2.1M -107.1M
Debt Repayment
3.4M 6.81M 2.1M n/a
Common Stock Repurchased
n/a -64.28M n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
3.4M 52.1M n/a 96K
Financial Cash Flow
3.4M 10.4M 2.1M 1.11M
Net Cash Flow
-780K 970K -747.3K 60K
Free Cash Flow
-4.18M -9.43M -747.3K -1.05M